Project title: RECOMBINANT TECHNOLOGY FOR THE GENERATION OF HIGHLY IMPROVED ENZYMES

Company name : PROTEREC LTD.


TECHNOLOGICAL FIELD
Biotechnology

KEY WORDS
Enzyme Improvement,
Industrial Biocatalysts, DNA Shuffling, DNA Homology


PROJECT SUMMARY
Proterec has developed a patented state-of-the-art recombinant
technology for the generation of synthetic enzymes of supreme
capabilities to serve as biocatalysts in key reactions of various
industrial processes.
The advantage of the technology lies in its ability to overcome
the limitations of DNA shuffling.


ENTREPRENEURS
Dr. Abraham Lavan - Founder & CEO
Dr. Gil Sharon - Founder & Chief
Investigator


PROJECT STATUS
The company was established in December 2002.
It is presently well into the process of proving its superior
ability to produce improved enzymes for more efficient industrial
biocatalytic processes, through the implementation of two
separate projects for the production of variant lipases and
ligases with enhanced capabilities to perform processes needed in
the industry. Those projects are being conducted in the framework
of business collaborations with large industrial firms.


COOPERATION REQUIRED
Investment and/or strategic alliances.
----------------------------------------------------------
TEL: 972-50-6392636; E-MAIL: alaban@proterec.com


Request for more information, about this project.

Note - you have to be registered in this server to request information. If you haven't done so yet, please:
Register in this server and your requests will be forwarded to the developer, who will contact you directly

List of projects that you already requested more information about


Incubator contact:
Dr. Idan Tamir
MIGDALEI ORR, 27 HABARZEL ST., TEL AVIV 69710, ISRAEL
972-3-7684944
972-3-7684941
info@radbiomed.com